{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T01:15:30Z","timestamp":1783991730163,"version":"3.55.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T00:00:00Z","timestamp":1686700800000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004748","name":"Mashhad University of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004748","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005013","name":"ACECR","doi-asserted-by":"publisher","award":["ACECR 3055\u201320"],"award-info":[{"award-number":["ACECR 3055\u201320"]}],"id":[{"id":"10.13039\/501100005013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Virus Eradication"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.jve.2023.100333","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T21:16:36Z","timestamp":1687209396000},"page":"100333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study"],"prefix":"10.1016","volume":"9","author":[{"given":"Sanaz","family":"Ahmadi Ghezeldasht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saman","family":"Soleimanpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Reza","family":"Hedayati-Moghaddam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moein","family":"Farshchian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Abdolrahim","family":"Rezaee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8408-4664","authenticated-orcid":false,"given":"Arman","family":"Mosavat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jve.2023.100333_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v13102053","article-title":"Molecular and serological characterisation of hepatitis B virus (HBV)-positive samples with very low or undetectable levels of HBV surface antigen","volume":"13","author":"Kuhns","year":"2021","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jve.2023.100333_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib4","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.tracli.2003.11.007","article-title":"Occult hepatitis B virus infection","volume":"11","author":"Allain","year":"2004","journal-title":"Transfus Clin Biol"},{"issue":"39","key":"10.1016\/j.jve.2023.100333_bib5","doi-asserted-by":"crossref","first-page":"8720","DOI":"10.3748\/wjg.v22.i39.8720","article-title":"Update on occult hepatitis B virus infection","volume":"22","author":"Makvandi","year":"2016","journal-title":"World J Gastroenterol"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2008.01.023","article-title":"Occult hepatitis B virus in liver tissue of individuals without hepatic disease","volume":"48","author":"Raimondo","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/j.jve.2023.100333_bib7","series-title":"Statements from the Taormina Expert Meeting on Occult Hepatitis B Virus Infection","author":"Samuel","year":"2008"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib8","first-page":"440","article-title":"Diagnostic strategy for occult hepatitis B virus infection and its clinical implications among patients at Upper Egypt","volume":"13","author":"El-Adly","year":"2020","journal-title":"JRRAS"},{"issue":"15","key":"10.1016\/j.jve.2023.100333_bib9","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3748\/wjg.v17.i15.1927","article-title":"An overview of occult hepatitis B virus infection","volume":"17","author":"Said","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"10","key":"10.1016\/j.jve.2023.100333_bib10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1111\/j.1537-2995.2009.02248.x","article-title":"Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico","volume":"49","author":"Calder\u00f3n","year":"2009","journal-title":"Transfusion"},{"issue":"10","key":"10.1016\/j.jve.2023.100333_bib11","first-page":"2214","article-title":"Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran","volume":"49","author":"Amini Kafi\u2010abad","year":"2009","journal-title":"2004 through 2007. Transfusion"},{"issue":"9-10","key":"10.1016\/j.jve.2023.100333_bib12","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4414\/smw.2008.12001","article-title":"Blood donor screening: how to decrease the risk of transfusion-transmitted hepatitis B virus?","volume":"138","author":"Niederhauser","year":"2008","journal-title":"Swiss Med Wkly"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.5812\/hepatmon.5934","article-title":"Epidemiology of occult hepatitis B infection among thalassemic, haemophilia, and hemodialysis patients","volume":"12","author":"Arababadi","year":"2012","journal-title":"Hepat Mon"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib14","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1537-2995.2008.01701.x","article-title":"Hepatitis B virus infection and transfusion medicine: science and the occult","volume":"48","author":"Hollinger","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib15","first-page":"46","article-title":"Occult hepatitis B virus infection: a case of reactivation in a patient receiving immunosuppressive treatment for allogeneic bone marrow transplantation","volume":"6","author":"Giudice","year":"2008","journal-title":"Blood Transfus"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib16","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.jhep.2019.03.034","article-title":"Taormina workshop on occult HBV infection faculty members. Update of the statements on biology and clinical impact of occult hepatitis B virus infection","volume":"71","author":"Raimondo","year":"2019","journal-title":"J Hepatol"},{"issue":"7","key":"10.1016\/j.jve.2023.100333_bib17","article-title":"Utility of HBV markers in detection of occult HBV colonization among sudanese blood donors","volume":"2","author":"Idrees","year":"2017","journal-title":"Afr J Med Sci"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib18","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1002\/jmv.21499","article-title":"Molecular characterisation of occult hepatitis B cases in Greek blood donors","volume":"81","author":"Katsoulidou","year":"2009","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jve.2023.100333_bib19","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jhep.2004.11.037","article-title":"Occult hepatitis B virus infection in a North American community-based population","volume":"42","author":"Minuk","year":"2005","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib20","first-page":"63","article-title":"Diagnosis and management of occult, hepatitis B virus infection: a short review","volume":"3","author":"Gonzalez","year":"2015","journal-title":"EMJ Hepatol."},{"key":"10.1016\/j.jve.2023.100333_bib21","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.meegid.2018.02.004","article-title":"Genotype characteristic and phylogenetic analysis of hepatitis B virus in northeast Iran","volume":"59","author":"Nodeh","year":"2018","journal-title":"Infect Genet Evol"},{"key":"10.1016\/j.jve.2023.100333_bib22","unstructured":"Alavian SM. Ministry of Health in Iran is serious about controlling hepatitis B. Hepat Mon.7(1):3-5."},{"key":"10.1016\/j.jve.2023.100333_bib23","unstructured":"Alavian SM, Gooya MM, Hajarizadeh B, Esteghamati AR, Moeinzadeh AM, Haghazali M, et al. Mass vaccination campaign against hepatitis B in adolescents in Iran: estimating coverage using administrative data. Hepat Mon.9(3):189-195."},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-018-3192-8","article-title":"Coinfection with hepatitis B virus among tuberculosis patients is associated with poor outcomes during anti-tuberculosis treatment","volume":"18","author":"Chen","year":"2018","journal-title":"BMC Infect Dis"},{"issue":"3","key":"10.1016\/j.jve.2023.100333_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.gastrohep.2018.03.003","article-title":"Reactivation of peritoneal and pleural tuberculosis during hepatitis C treatment with direct-acting antivirals","volume":"42","author":"Pedrosa","year":"2019","journal-title":"Gastroenterol Hepatol"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib26","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.bjid.2015.12.003","article-title":"High incidence of tuberculosis in patients treated for hepatitis C chronic infection","volume":"20","author":"de Oliveira Uehara","year":"2016","journal-title":"Braz J Infect Dis"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12879-016-1344-2","article-title":"Hepatitis C and not hepatitis B virus is a risk factor for anti-tuberculosis drug-induced liver injury","volume":"16","author":"Kim","year":"2016","journal-title":"BMC Infect Dis"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijmyco.2015.10.002","article-title":"Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: a cohort study","volume":"5","author":"Abera","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"issue":"8","key":"10.1016\/j.jve.2023.100333_bib29","first-page":"585","article-title":"[A meta-analysis of liver lesions in hepatitis B patients undergoing anti-tuberculosis therapy]","volume":"22","author":"Zheng","year":"2014","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1556\/1886.2021.00021","article-title":"Tuberculosis challenges: resistance, co-infection, diagnosis, and treatment","volume":"12","author":"Heidary","year":"2022","journal-title":"Eur. J. Microbiol. Immunol. (Bp)"},{"key":"10.1016\/j.jve.2023.100333_bib31","doi-asserted-by":"crossref","first-page":"e290","DOI":"10.1017\/S0950268820002861","article-title":"The role of hepatitis B infection in anti-tuberculosis drug-induced liver injury: a meta-analysis of cohort studies","volume":"148","author":"Zheng","year":"2020","journal-title":"Epidemiol Infect"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ijmyco.2015.10.001","article-title":"Antituberculosis drugs and hepatotoxicity among hospitalised patients in Jos, Nigeria","volume":"5","author":"Isa","year":"2016","journal-title":"Int. J. Mycobacteriol."},{"issue":"4","key":"10.1016\/j.jve.2023.100333_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jcv.2012.04.006","article-title":"Prevalence of hepatitis B virus infection among tuberculosis patients with or without HIV in Goi\u00e2nia City, Brazil","volume":"54","author":"Aires","year":"2012","journal-title":"J Clin Virol"},{"issue":"11","key":"10.1016\/j.jve.2023.100333_bib34","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.5588\/ijtld.15.0743","article-title":"Epidemiological study of hepatitis B virus among prisoners with active tuberculosis in Central Brazil","volume":"20","author":"Iglecias","year":"2016","journal-title":"IJTLD"},{"issue":"Pt 2","key":"10.1016\/j.jve.2023.100333_bib35","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1099\/jmm.0.47492-0","article-title":"Human immunodeficiency virus and tuberculosis in Argentina: prevalence, genotypes and risk factors","volume":"57","author":"Pando","year":"2008","journal-title":"J Med Microbiol"},{"issue":"6","key":"10.1016\/j.jve.2023.100333_bib36","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.jinf.2011.04.005","article-title":"Risk factors of hepatitis during anti-tuberculous treatment and implications of hepatitis virus load","volume":"62","author":"Wang","year":"2011","journal-title":"J Infect"},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib37","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ijid.2007.04.015","article-title":"Risk factors and algorithms to identify hepatitis C, hepatitis B, and HIV among Georgian tuberculosis patients","volume":"12","author":"Kuniholm","year":"2008","journal-title":"Int J Infect Dis"},{"issue":"12","key":"10.1016\/j.jve.2023.100333_bib38","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1007\/s10620-010-1413-0","article-title":"Occult hepatitis B: clinical implications and treatment decisions","volume":"55","author":"Schmeltzer","year":"2010","journal-title":"Dig Dis Sci"},{"issue":"9","key":"10.1016\/j.jve.2023.100333_bib39","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/jvh.12709","article-title":"Overt and occult hepatitis B virus infection among community children in Northwest China","volume":"24","author":"Su","year":"2017","journal-title":"J Viral Hepat"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s00705-013-1810-8","article-title":"Occult hepatitis B virus infection in Korean patients with isolated anti-HBc","volume":"159","author":"Kang","year":"2014","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib41","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jhep.2008.09.017","article-title":"Occult hepatitis B virus infection in hepatitis B vaccinated children in Taiwan","volume":"50","author":"Mu","year":"2009","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jve.2023.100333_bib42","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4254\/wjh.v7.i12.1671","article-title":"Occult hepatitis B virus infection in Egypt","volume":"7","author":"Elbahrawy","year":"2015","journal-title":"World J Hepatol"},{"issue":"7","key":"10.1016\/j.jve.2023.100333_bib43","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.14250","article-title":"Low prevalence of occult hepatitis B infection among blood donors in Beirut, Lebanon: reconsider the deferral strategy of anti-HBc positive blood donors","volume":"17","author":"El Banna","year":"2017","journal-title":"Hepat Mon"},{"issue":"9","key":"10.1016\/j.jve.2023.100333_bib44","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.14358","article-title":"Occult hepatitis B infection in Turkish HIV-infected patients: a multicentre, retrospective, cross-sectional study, Schindler study","volume":"75","author":"\u00dcnl\u00fc","year":"2021","journal-title":"Int J Clin Pract"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib45","article-title":"Detection of hepatitis B virus DNA (PCR) in HBsAg negative, anti-HBc positive blood donors in Tehran province","volume":"3","author":"Amini Kafi-abad","year":"2007","journal-title":"The Sci. J. Iran. Blood Transfus. Organ."},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib46","first-page":"38","article-title":"Occult hepatitis B demonstrated by anti-HBc and HBV DNA in HIV-positive patients","volume":"3","author":"Honarmand","year":"2014","journal-title":"Rep. Biochem. Mol. Biol."},{"issue":"1","key":"10.1016\/j.jve.2023.100333_bib47","first-page":"5","article-title":"Epidemiological profile of hepatitis B virus infection in Iran in the past 25 years; A systematic review and meta-analysis of general population studies","volume":"8","author":"Mohammadi","year":"2016","journal-title":"MEJDD"},{"issue":"4","key":"10.1016\/j.jve.2023.100333_bib48","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.35577","article-title":"Hepatitis B virus infection in the general population of Iran: an updated systematic review and meta-analysis","volume":"16","author":"Salehi-Vaziri","year":"2016","journal-title":"Hepat Mon"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib49","first-page":"0","article-title":"Occult hepatitis B virus infection among Iranian blood donors: a preliminary study","volume":"17","author":"Alizadeh","year":"2014","journal-title":"Arch Iran Med"},{"key":"10.1016\/j.jve.2023.100333_bib50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/2277-9175.188487","article-title":"Prevalence of occult hepatitis B virus infection in hemodialysis patients in Isfahan, Iran","volume":"5","author":"Kalantari","year":"2016","journal-title":"Adv Biomed Res"},{"issue":"3","key":"10.1016\/j.jve.2023.100333_bib51","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.16873","article-title":"Occult hepatitis B infection in patients with cryptogenic liver cirrhosis in the southwest Iran","volume":"8","author":"Hashemi","year":"2015","journal-title":"Jundishapur J Microbiol"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib52","first-page":"128","article-title":"Occult hepatitis B infection in chronic hemodialysis patients: comparison of results and concepts: occult HBV in chronic hemodialysis patients","volume":"11","author":"Ramezani","year":"2011","journal-title":"Hepat Mon"},{"key":"10.1016\/j.jve.2023.100333_bib53","series-title":"Occult hepatitis B virus infection among anti-HBc only positive individuals in the Southeast of Iran in high prevalence of HBV infection region","author":"Sanei-Muqaddim","year":"200911190"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib54","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1046\/j.1537-2995.2001.41050652.x","article-title":"Value of anti-HBc screening of blood donors for prevention of HBV infection: results of a 3-year prospective study in Northwestern Greece","volume":"41","author":"Zervou","year":"2001","journal-title":"Transfusion"},{"issue":"7","key":"10.1016\/j.jve.2023.100333_bib55","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.3390\/v14071504","article-title":"Occult hepatitis B virus infection: an update","volume":"14","author":"Saitta","year":"2022","journal-title":"Viruses"},{"issue":"2","key":"10.1016\/j.jve.2023.100333_bib56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1002\/hep.21529","article-title":"Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma","volume":"45","author":"Pollicino","year":"2007","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jve.2023.100333_bib57","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1053\/j.gastro.2004.08.003","article-title":"Occult hepatitis B virus infection in chronic liver disease: full-length genome and analysis of mutant surface promoter","volume":"127","author":"Chaudhuri","year":"2004","journal-title":"Gastroenterology"}],"container-title":["Journal of Virus Eradication"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664023000195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2055664023000195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:12:53Z","timestamp":1761855173000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2055664023000195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2055664023000195"],"URL":"https:\/\/doi.org\/10.1016\/j.jve.2023.100333","relation":{},"ISSN":["2055-6640"],"issn-type":[{"value":"2055-6640","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rate of occult hepatitis B virus infection among individuals with tuberculosis in northeastern Iran: A molecular epidemiological study","name":"articletitle","label":"Article Title"},{"value":"Journal of Virus Eradication","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jve.2023.100333","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100333"}}